BLFS Stock Summary and Trading Ideas (Biolife Solns | NASDAQ:BLFS)

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

Biolife Solns trades on the NASDAQ stock market under the symbol BLFS.

As of December 13, 2024, BLFS stock price declined to $26.70 with 238,515 million shares trading.

BLFS has a beta of 2.03, meaning it tends to be more sensitive to market movements. BLFS has a correlation of 0.23 to the broad based SPY ETF.

BLFS has a market cap of $1.24 billion. This is considered a Small Cap stock.

Last quarter Biolife Solns reported $31 million in Revenue and -$.02 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.07.

In the last 3 years, BLFS traded as high as $41.75 and as low as $8.92.

The top ETF exchange traded funds that BLFS belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.

BLFS has outperformed the market in the last year with a return of +92.2%, while the SPY ETF gained +29.9%. However, in the most recent history, BLFS shares have underperformed the stock market with its stock returning +6.3% in the last 3 month period and -2.8% for the last 2 week period, while SPY has returned +7.8% and +0.3%, respectively.

BLFS support price is $25.58 and resistance is $27.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BLFS shares will trade within this expected range on the day.